Biological Safety Testing Market Size 2024-2032, Growth Report

Biological Safety Testing Market – By Product and Services (Consumables, Instruments, Services, Reagents & Kits), Application (Gene Therapy, Stem Cells), Test Type (Endotoxin Test, Sterility Test, Bioburden Tests) – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising number of government initiatives and recommendations

3.2.1.2&nbsp;&nbsp;&nbsp;High R&amp;D investments in clinical research and life sciences research

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing production of new biologics due to high disease burden

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Time-consuming approval process

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product and Services, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Consumables

5.3&nbsp;&nbsp;&nbsp; Instruments

5.4&nbsp;&nbsp;&nbsp; Services

5.5&nbsp;&nbsp;&nbsp; Reagents and kits

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Vaccine and therapeutics

6.2.1&nbsp;&nbsp;&nbsp; Vaccines

6.2.2&nbsp;&nbsp;&nbsp; Monoclonal antibodies

6.2.3&nbsp;&nbsp;&nbsp; Recombinant protein

6.3&nbsp;&nbsp;&nbsp; Blood and blood-based products

6.4&nbsp;&nbsp;&nbsp; Gene therapy

6.5&nbsp;&nbsp;&nbsp; Tissue and tissue-based products

6.6&nbsp;&nbsp;&nbsp; Stem cells

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Endotoxin tests

7.3&nbsp;&nbsp;&nbsp; Sterility tests

7.4&nbsp;&nbsp;&nbsp; Mycoplasma tests

7.5&nbsp;&nbsp;&nbsp; Bioburden tests

7.6&nbsp;&nbsp;&nbsp; Residual host-cell proteins and DNA detection tests

7.7&nbsp;&nbsp;&nbsp; Virus safety tests

7.8&nbsp;&nbsp;&nbsp; Adventitious agent detection tests

7.9&nbsp;&nbsp;&nbsp; Other test types

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Argentina

8.5.3&nbsp;&nbsp;&nbsp; Mexico

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles 

9.1&nbsp;&nbsp;&nbsp; bioMerieux S.A.

9.2&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc.

9.3&nbsp;&nbsp;&nbsp; Eurofins Scientific SE

9.4&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

9.5&nbsp;&nbsp;&nbsp; Lonza Group Ltd

9.6&nbsp;&nbsp;&nbsp; Merck KGaA

9.7&nbsp;&nbsp;&nbsp; Samsung Biologics.

9.8&nbsp;&nbsp;&nbsp; Sartorius AG

9.9&nbsp;&nbsp;&nbsp; SGS Societe Generale de Surveillance SA

9.10&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

&nbsp;&nbsp;&nbsp;

Biological Safety Testing Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters